Aurora’s (TSX:ACB) Top 5 Most Brilliant Cannabis Acquisitions

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) topples competition with the acquisition of Hempco Food and Fiber.

| More on:
Silhouette of businessman sit on chair and hold a cigar and looking at the city in night.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The Aurora Cannabis (TSX:ACB)(NYSE:ACB) acquisition of Hempco Food and Fiber is another brilliant and purposeful branding move from Terry Booth, Aurora’s fearless founder and CEO.

The acquisition comes at the perfect time to purchase the stock below $8.00 per share. Aurora will now fully own the hemp-derived food and nutritional supplement brands, Planet Hemp and Praise.

The Hempco acquisition expands hemp-derived CBD extraction capacity to research and develop topical medical marijuana products. In fact, the Hempco acquisition is perfectly timed as its new, state-of-the-art Nisku facility nears completion.

The 56,000-square-foot facility will augment hemp processing to 2.9 million kilograms of hemp per year.

Cultivating cannabis from respected genetics research, Aurora Cannabis is quickly differentiating itself with a clear hemp-based strategy. In addition to the Hempco acquisition, Aurora has also established an extensive hemp value chain through strategic international partnerships and acquisitions.

Terry Booth is a genius when it comes to strategic expansions. Each one is clearly connected to the other in a purpose-driven way, demonstrating well-defined business development goals.

To date, Booth has led the company through 17 wholly-owned acquisitions of international cannabis assets.

Here are Aurora’s top 5 most brilliant hemp acquisitions and what they say about the man behind Aurora.

What Aurora’s top 5 hemp acquisitions say about CEO Terry Booth

  • Clearly, Terry Booth knows how to reach the European consumer: Agropro is Europe’s largest organic hemp-based food producer and boasts the best sowing and machine harvesting techniques to clean and extract CBD from hemp.
  • He understands that carbs and grease are the two most essential ingredients in hemp-derived food products: Borela’s network extends throughout the entire European Union in processing and distributing organic hemp seeds, flour, and oil.
  • He knows how to handle himself in rough neighbourhoods: Operating in the Latin American countries of Uruguay and Colombia, ICC labs exports CBD hemp genetics products for recreational and medicinal use.
  • Terry Booth will mass-produce clean munchies and other digestibles: Anandia Labs might be Aurora’s best acquisition. The asset expands Aurora’s organization knowledge of independent cannabis product testing and quality assurance.
  • He keeps his eye on the prize: Radient Technologies allows Aurora to manufacture cannabis at high volumes efficiently.

Perfectly complements UFC partnership

The hemp-based acquisition strategy perfectly complements Aurora’s recent collaboration with the UFC, the largest producer of global mixed martial arts events.

In May, Aurora and UFC announced a joint clinical research endeavour to explore uses for hemp-derived CBD. The UFC wants to learn about topical CBD treatments for mixed martial arts athletes.

Upon obtaining U.S. Anti-Doping Agency approval, the clinical research will result in hemp-derived athletic products under the ROAR sports brand. In order to establish additional credibility, Aurora will not directly conduct the investigation. Rather, the UFC will lead the clinical research study at the UFC Performance Institute in Las Vegas.

Non-intoxicating CBD products are critical to establishing a more extensive demographic reach beyond recreational users who may be more interested in the cognitive side effects.

Savvy Investors should keep a close eye on Aurora’s CBD development projects to stay on top of tomorrow’s innovative new brands.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »